[Anti-cancer monoclonal antibody]

Nihon Rinsho. 2005 Apr:63 Suppl 4:608-12.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Alemtuzumab
  • Aminoglycosides / therapeutic use
  • Animals
  • Antibodies, Monoclonal* / immunology
  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm / therapeutic use
  • Bevacizumab
  • Cetuximab
  • Clinical Trials as Topic
  • Gemtuzumab
  • Humans
  • Immunotherapy / methods
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Rituximab
  • Trastuzumab
  • Treatment Outcome

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm
  • Edrecolomab
  • Bevacizumab
  • Alemtuzumab
  • Rituximab
  • ibritumomab tiuxetan
  • Gemtuzumab
  • tositumomab I-131
  • Trastuzumab
  • Cetuximab